News & Insights
Research publications, platform milestones, press releases, technical resources, and thought leadership from Constructive Bio.
As featured in
- The Observer
- SynBioBeta
- Nature Biotechnology
- The Sunday Times
- UK Government DSIT
Constructive Bio, a leading synthetic biology company, today announces the appointment of Jim Weissman to its Board of Directors.
Company announcements, scientific updates, press releases, and external media coverage.
In-depth technical briefs, platform insights, and thought leadership for partners and researchers.
Genome synthesis is the ability to write DNA at the scale of entire chromosomes and genomes. It is fundamentally different…
Genetic code expansion uses whole-genome recoding to free up codons and assign them to amino acids that biology has never…
Genome synthesis is the ability to write DNA at the scale of entire chromosomes and genomes. It is fundamentally different…
Published research underpinning the Constructive Bio platform — from fundamental genetic code expansion to scalable biomanufacturing.
Syn57 dramatically expands the ‘codon space’ available for non-canonical amino acid incorporation, from three freed codons in Syn61 to seven…
Viral contamination is a major cost and quality risk in biomanufacturing. Phage infection can wipe out an entire production run,…
Speed matters in drug development. Automating tRNA generation means Constructive Bio can rapidly create the molecular machinery needed to incorporate…